
TSHA vs REPL
$TSHA vs $REPL head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
TSHA vs REPL: the quick read
- ·TSHA is the larger company by market cap ($1.46B vs $1.26B).
- ·REPL has been more active on our scanner (109 vs 74 alerts in 30 days).
- ·REPL has the smaller float (94.2M vs 290.0M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (Biological Products, (No Diagnostic Substances) vs BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)), so they answer to different catalysts and a move in one says little about the other.
- ·Both stay busy on our scanner, 109 and 74 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 16% of each other on market cap, which makes the rest of this table the interesting part.
- ·They have diverged badly over the year: REPL is near the top of its 52-week range while TSHA is near the bottom of its own.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing TSHA and REPL on TheDesperateTrader.
- Is TSHA or REPL the better stock?
- "Better" depends on your goal, and these two are not alike. TSHA is the larger company by market cap ($1.46B vs $1.26B). REPL has been more active on our scanner (109 vs 74 alerts in 30 days). REPL has the smaller float (94.2M vs 290.0M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between TSHA and REPL?
- The differences that matter: they are not in the same business - TSHA is biological products, (no diagnostic substances) and REPL is biological products, (no diagnostic substances); they are similar in size ($1.46B vs $1.26B); they trade at very different share prices ($4.49 vs $13.42); TSHA sits at 22% of its 52-week range against 80% for REPL; our scanner flagged TSHA 74 times in the last 30 days against 109 for REPL. Everything above is measured from the latest completed session and SEC filings.
- Which of TSHA and REPL is more active right now?
- Right now TSHA is at about 1.4x its normal volume and REPL is at about 0.9x, so TSHA is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading TSHA or REPL? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore TSHA and REPL comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.